[{"data":1,"prerenderedAt":135},["ShallowReactive",2],{"drug-pyridostigmine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":35,"contraindications":54,"warnings":64,"renal":65,"monitoring":66,"interactions":67,"review":68,"examples":71,"atc":72,"iran":74,"usApproval":94,"links":100,"populations":116},"pyridostigmine",1,{"fa":7,"en":8},"پیریدوستیگمین","Pyridostigmine","nervous-system",{"fa":11,"en":12},"مهارکننده کولین‌استراز","Cholinesterase inhibitor",[14],{"name":15,"market":16},"Mestinon","US",[18,19,7],"mestinon","مستینون",[21],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-30","tablet","oral","30 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},30,"mg",false,[16],[32],{"source":33,"section":34},"fda-pyridostigmine","Dosage and Administration",[36],{"id":28,"disease":37,"label":38,"population":41,"type":45,"unit":28,"dose":46,"refs":50},"myasthenia-gravis",{"fa":39,"en":40},"میاستنی گراویس — دوز و دفعات بر اساس پاسخ بیمار","Myasthenia gravis — dose and frequency by response",{"minAge":42},{"value":43,"unit":44},18,"year","notCalculated",{"reason":47},{"fa":48,"en":49},"برچسب: میانگین روزانه معادل ۶۰۰ mg (ده قرص ۶۰ mg) با فاصله‌گذاری برای بیشترین اثر؛ موارد خفیف ۱۲۰ تا ۷۲۰ mg و شدید تا ۱۵۰۰ mg در روز. پاسخ ضعیف ممکن است از کم‌دوزی یا بیش‌دوزی (بحران کولینرژیک) باشد.","Label: average daily total equivalent to 600 mg (ten 60 mg tablets), spaced for peak effect; mild cases 120–720 mg and severe up to 1,500 mg\u002Fday. Poor response may reflect under- or overdosing (cholinergic crisis).",[51,52],{"source":33,"section":34},{"source":33,"section":53},"Warnings",[55],{"id":56,"severity":57,"text":58,"refs":61},"ci","block",{"fa":59,"en":60},"انسداد مکانیکی روده یا مجاری ادراری؛ در آسم با احتیاط.","Mechanical intestinal or urinary obstruction; caution in asthma.",[62],{"source":33,"section":63},"Contraindications",[],[],[],[],{"status":69,"reviewer":70,"date":70},"unverified",null,[],[73],"N07AA02",{"status":75,"forms":76,"refs":89},"registered",[77,81,85],{"code":78,"en":79,"fa":80},"01079","PYRIDOSTIGMINE BROMIDE 10MG TAB","قرص پیریدوستیگمین بروماید ۱۰ میلی‌گرم",{"code":82,"en":83,"fa":84},"01080","PYRIDOSTIGMINE BROMIDE 60MG TAB","قرص پیریدوستیگمین بروماید ۶۰ میلی‌گرم",{"code":86,"en":87,"fa":88},"51600","PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE ORAL 180 mg","قرص آهسته‌رهش پیریدوستیگمین بروماید ۱۸۰ میلی‌گرم",[90],{"source":91,"section":92,"url":93},"darooyab-generic","G-3053\u002FPyridostigmine","https:\u002F\u002Fwww.darooyab.ir\u002FG-3053\u002FPyridostigmine",{"kind":95,"refs":96,"id":99},"ANDA",[97],{"source":33,"section":98},"SPL approval \u002F marketing category","ANDA211181",[101,104,108,111,114],{"kind":102,"url":103,"label":99},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=211181",{"kind":105,"url":106,"label":107},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=1aa7a886-c726-cc91-e063-6294a90a1af1","FDA Pyridostigmine",{"kind":109,"url":110,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682229.html",{"kind":112,"url":113,"label":73},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N07AA02",{"kind":115,"url":93,"label":8},"darooyab",{"pediatric":117,"pregnancy":126},{"level":118,"text":119,"quote":122,"refs":123},"not-established",{"fa":120,"en":121},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness in pediatric patients have not been established.",[124],{"source":33,"section":125},"Pediatric Use",{"level":127,"quote":128,"text":129,"refs":132},"caution","مصرف در بارداری پیریدوستیگمین گروه B قابل استفاده در بارداری:",{"fa":130,"en":131},"دارویاب: گروه B — فقط اگر فایده بیشتر از خطر باشد.","Darooyab: category B — only if benefit outweighs risk.",[133],{"source":91,"section":134,"url":93},"G-3053\u002FPyridostigmine — مصرف در بارداری",1792115193890]